Publicaties

Nass GCM, van Rens LW, Dijkstra BAG.  2019.  Clinicians' perceptions for indicating and contra-indicating integrated treatment for SUD and comorbid PTSD, a vignette study. Subst Abuse Treat Prev Policy. 14(1):7.

Leskauskas D, Adomaitienė V, De Jong CAJ, Vorevičiūtė B, Juknaitė R.  2018.  Changes over time in Lithuanian schoolchildren's attitudes toward addictive behaviors: Promoting and preventing factors.. PLoS One. 13(12):e0208481.

Duijvenbode vanN, Didden R, VanDerNagel JEL, Korzilius HPLM, Engels RCME.  2018.  Cognitive deficits in problematic drinkers with and without mild to borderline intellectual disability. Journal of Intellectual Disabilities. 22(1):5-17.

Lorenzetti V, Batalla A, Cousijn J.  2016.  Cannabis use disorders and neuroanatomical alterations: Where is the evidence? Current Addiction Reports. 3(2):189-198.

van Duijvenbode N, Didden R, VanDerNagel JEl, Korzilius HPlm, Engels RCme.  2016.  Cognitive deficits in problematic drinkers with and without mild to borderline intellectual disability.. J Intellect Disabil. :1744629516664840.

Emmelkamp P.M.G., Merkx M.JM, De Fuentes-Merillas L.  2015.  Contingency Management. Gedragstherapie. 48(2):153-170.

VanDerNagel JEl, Kiewik M, Postel MG, van Dijk M, Didden R, Buitelaar JK, DeJong CA.  2014.  Capture recapture estimation of the prevalence of mild intellectual disability and substance use disorder.. Res Dev Disabil. 35(4):808-13.

van Noorden MS, Kamal RM, Dijkstra BAG, Mauritz R, DeJong CA.  2014.  A Case Series of Pharmaceutical Gamma-Hydroxybutyrate in 3 Patients With Severe Benzodiazepine-Resistant Gamma-Hydroxybutyrate Withdrawal in the Hospital.. Psychosomatics.

Kiewik M, VanDerNagel JEl, Thijs AL.  2014.  Chronisch alcoholmisbruik bij mensen met een licht verstandelijke beperking. Nurse Academy. 1

Bruguera P, Ilzarbe D, Batalla A, Udina M, Roca JM, Pons A, Lomeña F, Martin-Santos R, Parellada E.  2014.  Clinical use of SPECT DaTSCAN in psychiatric population: one-year outcomes of a prospective case series. Psiquiatría Biológica. 21(1)

DeJong CA, de Kanter W.  2014.  [Commerce and psychoactive substances: beware Greeks bearing gifts].. Ned Tijdschr Geneeskd. 158:A8380.

Binelli C, Subirà S, Batalla A, Muñiz A, Sugranyés G, Crippa JA, Farré M, Pérez-Jurado L, Martin-Santos R.  2014.  Common and distinct neural correlates of facial emotion processing in social anxiety disorder and Williams syndrome: A systematic review and voxel-based meta-analysis of functional resonance imaging studies.. Neuropsychologia. 64C:205-217.

Schellekens A, DeJong CA, Buitelaar JK, Verkes RJ.  2014.  Co-morbid anxiety disorders predict early relapse after inpatient alcohol treatment.. Eur Psychiatry.

Schellekens A, Franke B, Ellenbroek B, Cools AR, DeJong CA, Buitelaar JK, Verkes RJ.  2012.  COMT Val158Met modulates the effect of childhood adverse experiences on the risk of alcohol dependence.. Addict Biol.

Postel MG, de Haan HA, Ter Huurne ED, Becker ES, DeJong CA.  2011.  Characteristics of problem drinkers in e-therapy versus face-to-face treatment.. Am J Drug Alcohol Abuse. 37(6):537-42.

de Haan HA, Joosten EAG, Wijdeveld AGM, Boswinkel PB, van der Palen J, DeJong CA.  2011.  Cognitive behavioural treatment is as effective in high- as in low-scoring alexithymic patients with substance-related disorders.. Psychother Psychosom. 80(4):254-5.

Linka T, Sartory G, Gastpar M, Scherbaum N, Müller BW.  2009.  Clinical symptoms of major depression are associated with the intensity dependence of auditory event-related potential components.. Psychiatry Res. 169(2):139-43.

DeJong CA, De Fuentes-Merillas L, Verbrugge C.  2009.  Community Reinforcement Approach en vouchersbehandeling. Verslaving: Handboek voor zorg, begeleiding en preventie.